Ironwood Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This assessment of Ironwood Pharmaceuticals Inc uses information from across the internet and also from available documents by Ironwood Pharmaceuticals Inc. Complete ESG analysis of Ironwood Pharmaceuticals Inc can be accessed by logging in. If you are employed by Ironwood Pharmaceuticals Inc and you wish to licence your ESG rating, please contact us.
Ironwood Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 4.6, social score of 4.0 and governance score of 5.0.
4.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1121 | Protagonist Therapeutics Inc | 4.8 | High |
| 1121 | Shanghai Medicilon Inc | 4.8 | High |
| 1156 | Ironwood Pharmaceuticals Inc | 4.7 | High |
| 1156 | Albireo Pharma Inc | 4.7 | High |
| 1156 | Adaptimmune Therapeutics PLC | 4.7 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ironwood Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ironwood Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ironwood Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ironwood Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Ironwood Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ironwood Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ironwood Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.